Source:http://linkedlifedata.com/resource/pubmed/id/12901803
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2003-8-6
|
pubmed:abstractText |
Nuclear factor kappa B (NF-kappa B) is a transcription factor that is known to regulate apoptosis when cells are exposed to DNA-damaging agents such as ionizing radiation and cytotoxic drugs. We sought to determine if inhibition of NF-kappa B could enhance radiosensitivity in human colon cancer cells in vitro and in vivo. To inhibit NF-kappa B activation specifically, we constructed a recombinant adenovirus vector expressing a truncated form of the inhibitor protein I kappa B alpha (I kappa B alpha Delta N) that lacks the phosphorylation sites essential for activation of NF-kappa B, and transfected two human colon cancer cell lines (HT29 and HCT15) with this vector. In vitro colony-forming assays revealed that the overexpression of the stable I kappa B alpha by AxI kappa B alpha Delta N infection significantly suppressed cell growth after irradiation in both cell lines as compared to infection with a control vector, AxLacZ. Treatment with AxI kappa B alpha Delta N and irradiation successfully inhibited the growth of HT29 xenografted subcutaneous tumors in nude mice with an 83.8% volume reduction on day 38 as compared to the untreated tumors. Furthermore, it was demonstrated that apoptosis was increased by adenovirus-mediated gene transduction of I kappa B alpha Delta N in vitro and in vivo. These results indicated that inhibition of NF-kappa B could enhance radiosensitivity through an increase in radiation-induced apoptosis. We believe that radio-gene therapy using adenovirus-mediated gene transduction of I kappa B alpha Delta N could be an attractive candidate as a treatment strategy for colorectal cancer.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1347-9032
|
pubmed:author |
pubmed-author:FujiiHisaoH,
pubmed-author:KoyamaFumikazuF,
pubmed-author:MatsumotoHiroshiH,
pubmed-author:MukogawaTomohideT,
pubmed-author:NakajimaYoshiyukiY,
pubmed-author:ShimizuNobuyoshiN,
pubmed-author:TachibanaMasaakiM,
pubmed-author:TakayanagiAtsushiA,
pubmed-author:TakeuchiTakuT,
pubmed-author:UenoMasatoM
|
pubmed:issnType |
Print
|
pubmed:volume |
94
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
745-50
|
pubmed:dateRevised |
2006-4-21
|
pubmed:meshHeading |
pubmed-meshheading:12901803-Adenoviridae,
pubmed-meshheading:12901803-Cell Line,
pubmed-meshheading:12901803-Cell Survival,
pubmed-meshheading:12901803-Colonic Neoplasms,
pubmed-meshheading:12901803-Dose-Response Relationship, Radiation,
pubmed-meshheading:12901803-Genetic Vectors,
pubmed-meshheading:12901803-Humans,
pubmed-meshheading:12901803-I-kappa B Proteins,
pubmed-meshheading:12901803-NF-kappa B,
pubmed-meshheading:12901803-Radiation Tolerance,
pubmed-meshheading:12901803-Recombinant Proteins,
pubmed-meshheading:12901803-Transfection,
pubmed-meshheading:12901803-Tumor Cells, Cultured,
pubmed-meshheading:12901803-X-Rays
|
pubmed:year |
2003
|
pubmed:articleTitle |
Adenovirus-mediated gene transduction of truncated I kappa B alpha enhances radiosensitivity in human colon cancer cells.
|
pubmed:affiliation |
First Department of Surgery, Nara Medical University, Kashihara, Nara 634-8522, Japan. tmuko@naramed-u.ac.jp
|
pubmed:publicationType |
Journal Article
|